Psoriatic arthritis
New technique may offer superior pain relief over traditional spinal cord stimulation
A medical device company has announced the results of a study that show its device is better than traditional spinal cord stimulation in terms of relieving chronic pain.
Known as Burst stimulation, the new device gives intermittent “burst” pulses designed to mimic the body’s natural nerve firing patterns so theoretically provides a more physiologically-based method for chronic pain conditions. Continue reading
World’s first ibuprofen patch delivers pain relief directly through skin
An ibuprofen patch that delivers the drug directly through skin to exactly where it is needed at a consistent dose rate, has been invented in the UK. A team from the University of Warwick found a way to incorporate significant amounts of ibuprofen (up to 30% weight) into the polymer matrix that sticks the patch to the patient’s skin with the drug then being delivered at a steady rate over up to 12 hours. Continue reading
Doctor-patient relationship key to successful outcome of treatment in psoriatic arthritis
People with psoriatic arthritis who are misaligned with their rheumatologist may have worse outcomes, a research group revealed at the American College of Rheumatology Annual Meeting. Continue reading
Discovery of a molecular switch to stop inflammation?
A molecular switch – MYSM1 – may be able to suppress the overreaction of the immune system and could prevent inflammatory diseases experts claim in Immunity.
Although the immune system is vital for protection and healing, it can overreact causing chronic inflammatory diseases, such as rheumatoid arthritis. Continue reading
New drug – secukinumab – may help people with psoriatic arthritis
People with psoriatic arthritis had improvements in skin and joint symptoms after treatment with secukinumab (Cosentyx) according to the results of a phase 3 study published in the New England Journal of Medicine. Scientists split 606 people with psoriatic arthritis into groups: Continue reading
